dievini Hopp BioTech holding
Also known as dievini, dievini Hopp BioTech holding GmbH & Co. KG
Walldorf life-sciences holding controlled by SAP co-founder Dietmar Hopp; main shareholder of Heidelberg Pharma and formerly of CureVac (acquired by BioNTech in 2025).
USEFUL FOR Co-investors
Life-sciences investment vehicle controlled by SAP co-founder Dietmar Hopp. Not to be confused with the Dietmar Hopp Stiftung (charitable foundation, St. Leon-Rot) or other Hopp vehicles such as DH-LT-Investments.
Family & background
- FAMILY
- Hopp
- WEALTH ORIGIN
- SAP (Dietmar Hopp, co-founder)
- HEADQUARTERS
- Walldorf, Germany
Investment approach
- ROUTES
- Companies (own capital)
Overview
dievini Hopp BioTech holding GmbH & Co. KG, Walldorf, is a life-sciences investment company that Heidelberg Pharma's 2025 annual report lists among the companies controlled by Dietmar Hopp, co-founder of SAP. Its general partner is dievini Verwaltungs GmbH, whose managing director is Dr. Mathias Hothum. It is the main shareholder of Heidelberg Pharma, where Dietmar Hopp, related parties and companies they control held 44.1% at 30 November 2025. It was a major shareholder of CureVac and backed BioNTech's acquisition of the company in 2025.
Holdings & investments (3)
- CureVacNOTABLEBiotech & Life Sciences · Acquired by BioNTech (exchange offer completed Dec 2025)
- Heidelberg PharmaNOTABLEBiotech & Life Sciences · Main shareholder (Hopp-controlled companies 44.1%, Nov 2025)
- HealthTech · Affiliated company of dievini (per Heidelberg Pharma 2025 report)
People
- Dr. Mathias HothumManaging Director, dievini Verwaltungs GmbH (general partner) · source
Frequently asked questions
dievini Hopp BioTech holding is a family holding based in Walldorf, Germany.
dievini Hopp BioTech holding invests on behalf of the Hopp family (SAP (Dietmar Hopp, co-founder)).
dievini Hopp BioTech holding invests directly in companies. Capital origin: the family's own capital.
dievini Hopp BioTech holding invests in Biotech & Life Sciences and HealthTech.
Key people at dievini Hopp BioTech holding include Dr. Mathias Hothum (Managing Director, dievini Verwaltungs GmbH (general partner)).
dievini Hopp BioTech holding's disclosed holdings and investments include CureVac, Heidelberg Pharma and Molecular Health.